Inhibition of the SH3 domain-mediated binding of Src to the androgen receptor and its effect on tumor growth
β Scribed by Migliaccio, A; Varricchio, L; De Falco, A; Castoria, G; Arra, C; Yamaguchi, H; Ciociola, A; Lombardi, M; Di Stasio, R; Barbieri, A
- Book ID
- 110072483
- Publisher
- Nature Publishing Group
- Year
- 2007
- Tongue
- English
- Weight
- 334 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Fibroblast growth factor (FGF)β2 regulates a variety of cellular functions, such as proliferation and differentiation, by binding to cell surface FGF receptors (FGFRs) in the presence of heparin proteoglycans. FGFβ2 is known as a heparinβbinding growth factor, but the localization of th
p105CasL (CasL) is a recently identified signaling molecule closely related to the p130Cas (Crk-associated substrate) docking protein. CasL has a single Src homology (SH) 3 domain in its N-terminal portion followed by multiple consensus motifs for binding to SH2 domains. Like original p130Cas, CasL